Sevelamer, a phosphate-binding resin with beneficial effect in diabetic kidney disease; a modern paradigm shift

Azar Baradaran ¹, Saeed Mardani ², Mohammad-Reza Tamadon ³, Heshmatollah Shahbazian ⁴, Seyed Seifollah Beladi Mousavi ⁴^*

¹ Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
² Department of Nephrology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
³ Department of Nephrology, Semnan University of Medical Sciences, Semnan, Iran.
⁴ Chronic Renal Failure Research Center, Ahvaz Junishapur University of Medical Sciences, Ahvaz, Iran.

*Corresponding Author: *Corresponding author: Seyed Seifollah Beladi Mousavi,, Email: beladimusavi@yahoo.com

Implication for health policy/practice/research/medical education

Recent clinical and preclinical investigations have detected glucose and lipid-lowering effects of sevelamer, which imply the role of this drug in the treatment of type II diabetic patients.

Please cite this paper as: Baradaran A, Mardani S, Tamadon MR, Shahbazian H, Beladi Mousavi SS. Sevelamer, a phosphate-binding resin with beneficial effect in diabetic kidney disease; a modern paradigm shift. J Parathyr Dis 2014; 2(2): 61-62.